We are live on ! Find out more
AEMD icon

Aethlon Medical

22 hedge funds and large institutions have $270K invested in Aethlon Medical in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01%0% (-0%)

4% less funds holding

Funds holding: 2322 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

30% less capital invested

Capital invested by funds: $388K → $270K (-$118K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 6

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
6
Closed
4
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$12K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
-$13.2K -43 Closed
Bank of New York Mellon
27
Bank of New York Mellon
New York
-$10.7K -35 Closed
Simplex Trading
28
Simplex Trading
Illinois
-$5.56K -19 -95%
PGAM
29
Princeton Global Asset Management
New Jersey
-$6

AEMD Hedge Fund Activity: Q2 2023 in Review

22 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2023, worth a combined $270K — down 30% from $388K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AEMD and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 0 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $7.32K. The largest seller was HRT Financial, exiting entirely with an estimated $41K sold.

  • 22 institutional investors held Aethlon Medical (AEMD) as of Q2 2023, down from 23 in Q1 2023.
  • Funds reported $270K of Aethlon Medical stock for Q2 2023, down 30% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q2 2023 and 4 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q2 2023 was Renaissance Technologies, an estimated $7.32K added.
  • The largest Aethlon Medical seller in Q2 2023 was HRT Financial, an estimated $41K sold.

Based on aggregated 13F filings for Q2 2023.